Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (29)

2023

  1. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

  4. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

    Antioxidants, Vol. 12, Núm. 2

  5. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  6. Targeting inflammation to treat diabetic kidney disease: the road to 2030

    Kidney International, Vol. 103, Núm. 2, pp. 282-296

  7. The Value of Klotho in Kidney Transplantation

    Transplantation, Vol. 107, Núm. 3, pp. 616-627

2022

  1. Electronic Patient-Reported Outcomes in Nephrology: Focus on Hemodialysis

    Journal of Clinical Medicine, Vol. 11, Núm. 3

  2. Osteoporosis in chronic kidney disease: A essential challenge

    Medicina Clinica, Vol. 158, Núm. 1, pp. 27-34

  3. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213

  4. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell

    Nefrologia, Vol. 42, Núm. 6, pp. 645-655

  5. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study

    Biomedicine and Pharmacotherapy, Vol. 154

  6. The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure

    Clinical Kidney Journal, Vol. 15, Núm. 5, pp. 865-872

2021

  1. Interleukin-17A: Potential mediator and therapeutic target in hypertension

    Nefrologia

  2. Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257

  3. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

    Scientific Reports, Vol. 11, Núm. 1

  4. Mortality in hemodialysis patients with covid-19, the effect of paricalcitol or calcimimetics

    Nutrients, Vol. 13, Núm. 8

  5. Optimizing the timing of nephrology referral for patients with diabetic kidney disease

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8

  6. Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: The VELREAL multicentre study

    Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 681-687

  7. Setting up a cardiorenal clinic. Consensus document of the cardiorenal working groups of the Spanish Society of Cardiology and the Spanish Society of Nephrology

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 284-295